Phase III B in Acute Lymphoblastic Leukemia
Clinical trial NCT03123939 · COMPLETED
Trial details
- NCT number
- NCT03123939
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2020-10-13
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.